{
    "clinical_study": {
        "@rank": "110819", 
        "arm_group": [
            {
                "arm_group_label": "Self expanding metallic stent \uff08SEMS \uff09placement only", 
                "arm_group_type": "Active Comparator", 
                "description": "Endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic cholangiography (PTC) would be performed to confirm the position and length of the biliary malignant. A self expanding metallic stent (SEMS) would be placed to bypass the site of narrowing"
            }, 
            {
                "arm_group_label": "Endoscopic radiofrequency ablation plus SEMS", 
                "arm_group_type": "Experimental", 
                "description": "Endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic cholangiography (PTC) would be performed to confirm the position and length of the biliary malignant. The radiofrequency ablation (RFA) catheter (EMcision, London, United Kingdom) would be placed under fluoroscopic guidance across the biliary stricture. Radiofrequency energy will be delivered to the malignant site. After that,A self expanding metallic stent (SEMS) would be placed to bypass the site of narrowing"
            }, 
            {
                "arm_group_label": "Photodynamic therapy plus SEMS", 
                "arm_group_type": "Experimental", 
                "description": "Photofrin is injected 3 days prior to laser activation of the agent.Endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic cholangiography (PTC)  will be carried out to determine the length and positon of the biliary malignant. Delivery Fiber used along with the laser system to activate the photosensitizing agent and induce tumor tissue necrosis. A self expanding metallic stent (SEMS) will be placed the site of biliary narrowing"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare endoscopic radiofrequency ablation with photodynamic\n      therapy for inoperable cholangiocarcinoma"
        }, 
        "brief_title": "Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma", 
        "condition": "Cholangiocarcinoma", 
        "condition_browse": {
            "mesh_term": "Cholangiocarcinoma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u2265 18 years old\n\n          -  Pathologically or radiologically confirmed biliary malignant\n\n          -  Inoperability by staging\n\n        Exclusion Criteria:\n\n          -  Cholangiocarcinoma with widespread metastasis\n\n          -  Coagulopathy (INR > 2.0 or prothrombin time > 100 sec or platelet count < 50,000)\n\n          -  Prior SEMS placement\n\n          -  Pregnancy\n\n          -  Eastern Cooperative Oncology Group (ECOG) performance status \u2265 3 )\n\n          -  Life expectancy < 3months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01739465", 
            "org_study_id": "RFA2012"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Self expanding metallic stent \uff08SEMS \uff09placement only", 
                    "Endoscopic radiofrequency ablation plus SEMS", 
                    "Photodynamic therapy plus SEMS"
                ], 
                "description": "Self expanding metallic stent", 
                "intervention_name": "Self expanding metallic stent (SEMS)", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Endoscopic radiofrequency ablation plus SEMS", 
                "description": "Endoscopic radiofrequency ablation", 
                "intervention_name": "Endoscopic radiofrequency ablation (ERFA)", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Photodynamic therapy plus SEMS", 
                "description": "Photodynamic therapy", 
                "intervention_name": "Photodynamic therapy (PDT)", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cholangiocarcinoma", 
            "Pathologic", 
            "Digestive System", 
            "Neoplasms", 
            "Neoplasms by Site", 
            "Digestive System Diseases", 
            "Bile Duct Diseases", 
            "Biliary Tract Diseases", 
            "Pathological Conditions", 
            "Constriction", 
            "Adenocarcinoma", 
            "Carcinoma"
        ], 
        "lastchanged_date": "February 25, 2013", 
        "location": [
            {
                "contact": {
                    "email": "beanth@163.com", 
                    "last_name": "Huihong Liang, MD", 
                    "phone": "+86-188-2648-8232"
                }, 
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510260"
                    }, 
                    "name": "The Second Hospital of Guangzhou Medical College"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "beanth@163.com", 
                    "last_name": "Huihong Liang, Doctorial", 
                    "phone": "+86-188-2648-8232"
                }, 
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510260"
                    }, 
                    "name": "The second hospital of Guangzhou Medical college"
                }, 
                "investigator": {
                    "last_name": "Huihong Liang, Doctoral", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Randomized Controlled Trial Comparing Endoscopic Biliary Radiofrequency Ablation With Photodynamic Therapy for Inoperable Cholangiocarcinoma", 
        "overall_contact": {
            "email": "beanth@163.com", 
            "last_name": "Huihong Liang, MD", 
            "phone": "+86-20-34153043"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Science and Technology Commission of Guangzhou"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "stent patency", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01739465"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Guangzhou Medical University", 
            "investigator_full_name": "Huihong Liang", 
            "investigator_title": "Associated Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "overall survival rate", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "source": "Guangzhou Medical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Guangzhou Medical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}